Tracheostomy tube insertion is periodically performed when @entity1 with @entity791 ( @entity791 ) require prolonged mechanical ventilation. In this population, bedside percutaneous tracheostomy may be a better technique than conventional operating room tracheostomy because it reduces procedural cost, requires no @entity1 transport, and requires few sharp instruments, thereby potentially decreasing risk to surgical staff. A retrospective review was conducted in the Department of Medical Records at St. Vincents Hospital and Medical Center of New York City. Nine consecutive @entity1 diagnosed with @entity791 and undergoing percutaneous tracheostomy from January 1, 1992, to December 31, 1996, were identified. All @entity1 were males (mean age 32.1 +/- 4 years, @entity404 count average 145) and were ventilator-dependent for mean of 24 +/- 3 days. The procedure was successful and without complications in all @entity1 . Follow-up was 27 months (range 1-42 months) and in-hospital mortality was 77 per cent. The average length of survival for those @entity1 who died in the hospital was 29 days (range, 3-120). Two @entity1 survived the hospitalization after undergoing decannulation on postoperative days 29 and 52, respectively. Despite the poor prognosis after tracheostomy in @entity1 with @entity791 this procedure allows better oral care and may improve @entity1 comfort. Bedside percutaneous tracheostomy can be performed with less risk to surgical personnel and @entity1 when compared to conventional surgery. This minimally invasive procedure safely and efficiently provides prolonged tracheal access in @entity1 with @entity791 .

Bedside percutaneous tracheostomy in XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity791 :: ('MESH:D000163', 'Disease') :: ['acquired immunodeficiency syndrome', 'AIDS'] @entity404 :: ('920', 'Gene') :: ['CD4']
@entity791 :: (MESH:D000163,Disease) :: ['acquired immunodeficiency syndrome']
